期刊文献+

HPLC法测定水飞蓟素胶囊中水飞蓟素异构体的含量 被引量:3

Determination of Six Isomers of Silibin in Silymarin Capsules by HPLC
暂未订购
导出
摘要 目的建立水飞蓟素胶囊中水飞蓟素异构体的含量测定方法方法采用HPLC法,C18色谱柱(125mm×4.0mm,5μm);流动相为混合溶剂A[85%磷酸-甲醇-水(5∶35∶65)]和混合溶剂B[85%磷酸-甲醇-水(5∶50∶50)]梯度洗脱;流速:0.8mL/min;检测波长为288nm。结果水飞蓟宾在0.5088~2.5440μg范围内呈良好线性关系;加样回收率为99.5%,RSD=2.2%。结论该方法采用水飞蓟宾为对照品,在同一流动相条件下能够同时测定6种水飞蓟素异构体的含量,可用于水飞蓟素胶囊的质量控制。 Objective To establish a method for the determination of 6 isomers of silibin in silymarin Capsules. Method The RP - HPLC method was applied. Separation and determination of silibinin was performed on a ClS column( 125 mm × 4.0 mm) with the flow rate of 0.8 mL/min, temperature at 25 ℃ and detection wavelength at 288 nm. The mixed solvent of A (85 % phosphoric acid : methnol : water = 5 : 35 : 65) and B (85 % phosphoric acid : methnol : water = 5 : 50 : 50) served as the mobile phase (gradient elution). Results A good linearity of silibinin was in the rang of 0. 508 8 2. 544 0 μg( r = 0.999 8). The average recovery was 99.5 % and RSD was 2.2 % ( n = 5). Conclusion With silibinin as as the control, this method is simple and accurate and can be used for the determination of six isomers of silibin and can be used for quality control of Silymarin Capsules.
出处 《中药新药与临床药理》 CAS CSCD 2006年第3期200-202,共3页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 水飞蓟素胶囊 水飞蓟素 异构体 水飞蓟宾 HPLC 含量测定 Silymarin Capsule Silibin Isomer Silibinin HPLC Content determination
  • 相关文献

参考文献4

二级参考文献8

共引文献21

同被引文献16

  • 1王雯佶,张纯,檀密艳,高申.高效液相色谱法测定肝泰胶囊中水飞蓟宾的含量[J].中国药房,2006,17(22):1736-1737. 被引量:1
  • 2黄欣,张哲永.当飞利肝宁胶囊治疗非酒精性脂肪性肝病32例临床观察[J].中医杂志,2007,48(6):524-525. 被引量:23
  • 3SALLER R,MEIER R, BRIGNOLI R. The use of si- lymarin in the treatment of liver diseases E J ]. Drugs, 2001,61 (14) :2035 - 2063.
  • 4黄大有,赵苗生,吴晶新.利肝隆与益肝灵治疗乙型肝炎的疗效对比[J].北京医学院学报,1978(3):182-184.
  • 5POLYAK S J, MORISHIMA C, LOHMANN V, et al. Identification of hepatoprotective flavonolignans from silymarin [ J 1. Proceedings of the National Academy of Sciences of the United States of America, 2010,107 ( 13 ) :5995 - 5999.
  • 6AHMED-BELKACEM A,AHNOU N,BARBOTIE L, et al. Silibinin and related compounds are direct inhibi- tors of hepatitis C virus RNA-dependent RNA polymer- ase [ J ]. Gastroenterology ,2010,138 (3) : 1112 - 1122.
  • 7L1N An-shen, SHIBANO M, NAKAGAWA-GOTO K, et al. Cancer preventive agents. 7. Antitumor-pro- moting effects of seven active flavonolignans from milk thistle( Silybum marianum. )on epstein-barr virus activation ~ J ]. Pharmaceutical Biology, 2007,45 (10) : 735 - 738.
  • 8KVASNICKA F, BIBA B, SEVCIK R, et al. Analysisof the active components of silymarin I J 1. Journal of Chromatography A, 2003,990 ( 1 ) : 239 - 245.
  • 9QUAGLIA M G, BOSSU E, DONATI E, et al. Deter- mination of silymarin in the extract from the dried Silybum marianum fruits by high performance liquid chromatography and capillary electrophoresis [ J ]. Journal of Pharmaceutical & Biomedical Analysis, 1999,19 ( 3 ) :435 - 442.
  • 10LIU Hong, DU Zhen-xia, YUAN Qi-peng. A novel rapid method for simultaneous determination of eight active compounds in silymarin using a reversed-phase UPLC-UV detector I J 3. Journal of Chromatography B,2009,877(32) :4159 -4163.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部